Scoping the Design Space for Generic Nasal Sprays

In this article, Deborah Huck-Jones, PhD, Product Manager, Analytical Imaging; and Paul Kippax, PhD, Micrometrics Product Group Manager & Pharmaceutical Portfolio Manager, both of Malvern Instruments, discuss analytical methods that can be helpful for demonstrating bioequivalence in the development of generic nasal sprays, highlighting the importance of understanding how spray formulations and devices interact to impact drug delivery performance.

In this article, Deborah Huck-Jones, PhD, Product Manager, Analytical Imaging; and Paul Kippax, PhD, Micrometrics Product Group Manager & Pharmaceutical Portfolio Manager, both of Malvern Instruments, discuss analytical methods that can be helpful for demonstrating bioequivalence in the development of generic nasal sprays, highlighting the importance of understanding how spray formulations and devices interact to impact drug delivery performance.

Inicio de sesión

¿Olvidó su contraseña?
Not registered yet? Create an account